We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.SETTLEMENT AGREEMENT AND GENERAL RELEASESettlement Agreement • October 15th, 2021 • Teligent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 15th, 2021 Company Industry JurisdictionThis Settlement Agreement and General Release (the “Agreement”) is made by and among: (i) Philip K. Yachmetz (“Executive”); (ii) Teligent, Inc. (the “Company”); (iii) ACF FinCo I LP (“ACF”); and (iv) Ares Capital Corporation (“ACC” and, collectively with the Company and ACF, the “Corporate Parties”) (Executive and the Corporate Parties are collectively referred to as the “Parties”).
AMENDED AND RESTATED SETTLEMENT AGREEMENT AND GENERAL RELEASESettlement Agreement • October 15th, 2021 • Teligent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 15th, 2021 Company Industry JurisdictionThis Amended and Restated Settlement Agreement and General Release (this “Agreement”) is made by and among: (i) Timothy B. Sawyer (“Executive”); (ii) Teligent, Inc. (the “Company”); (iii) ACF FinCo I LP (“ACF”); and (iv) Ares Capital Corporation (“ACC” and, collectively with the Company and ACF, the “Corporate Parties”) (Executive and the Corporate Parties are collectively referred to as the “Parties”) and amends and supersedes that certain Settlement Agreement and General Release, dated October 8, 2021, by and among the Parties (the “Original Agreement”).